Sproxil is combating the global counterfeit drug ...
Sproxil is combating the global counterfeit drug market through a Mobile Product Authentication™ (MPA™) solution that enables consumers to verify the authenticity of pharmaceutical products. Sproxil’s MPA solution allows customers to send a free text message containing a code found on a drug to Sproxil’s servers, which immediately respond and indicate whether the drug is genuine or fake. Sproxil has set up Africa’s first national mobile-based anti-counterfeit service in Nigeria, and Acumen Fund’s investment will enable the company to expand into Kenya and India.
Funding and Financing Rounds
Impact Reports & Metrics
Boston, Massachusetts US